Carter, B. Z., Mak, P. Y., Mak, D. H., Ruvolo, V. R., Schober, W., McQueen, T., . . . Andreeff, M. (2015). Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34(+) proliferating and quiescent chronic myeloid leukemia blast crisis cells. Oncotarget.
Citação norma ChicagoCarter, Bing Z., et al. "Synergistic Effects of P53 Activation Via MDM2 Inhibition in Combination With Inhibition of Bcl-2 or Bcr-Abl in CD34(+) Proliferating and Quiescent Chronic Myeloid Leukemia Blast Crisis Cells." Oncotarget 2015.
MLA citiranjeCarter, Bing Z., et al. "Synergistic Effects of P53 Activation Via MDM2 Inhibition in Combination With Inhibition of Bcl-2 or Bcr-Abl in CD34(+) Proliferating and Quiescent Chronic Myeloid Leukemia Blast Crisis Cells." Oncotarget 2015.